2HXZ
Crystal Structure of Cathepsin S in complex with a Nonpeptidic Inhibitor (Hexagonal spacegroup)
Summary for 2HXZ
Entry DOI | 10.2210/pdb2hxz/pdb |
Related | 2H7J |
Descriptor | Cathepsin S, SULFATE ION, N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE, ... (4 entities in total) |
Functional Keywords | cathepsin s, nonpeptidic, chloromethylketone, substrate activity screening, hydrolase |
Biological source | Homo sapiens (human) |
Cellular location | Lysosome: P25774 |
Total number of polymer chains | 3 |
Total formula weight | 74375.66 |
Authors | Patterson, A.W.,Wood, W.J.,Hornsby, M.,Lesley, S.,Spraggon, G.,Ellman, J.A. (deposition date: 2006-08-04, release date: 2006-10-24, Last modification date: 2023-08-30) |
Primary citation | Patterson, A.W.,Wood, W.J.,Hornsby, M.,Lesley, S.,Spraggon, G.,Ellman, J.A. Identification of selective, nonpeptidic nitrile inhibitors of cathepsin s using the substrate activity screening method. J.Med.Chem., 49:6298-6307, 2006 Cited by PubMed Abstract: The substrate activity screening method, a substrate-based fragment identification and optimization method for the development of enzyme inhibitors, was previously applied to cathepsin S to obtain low nanomolar 1,4-disubstituted-1,2,3-triazole-based aldehyde inhibitors (Wood, W. J. L.; Patterson, A. W.; Tsuruoka, H.; Jain, R. K.; Ellman, J. A. J. Am. Chem. Soc. 2005, 127, 15521-15527). Replacement of the metabolically labile aldehyde pharmacophore with the nitrile pharmacophore provided inhibitors with moderate potency for cathepsin S. The inhibitors showed good selectivity over cathepsins B and L but no selectivity over cathepsin K. X-ray structures of two crystal forms (1.5 and 1.9 A) of a complex between cathepsin S and a triazole inhibitor incorporating a chloromethyl ketone pharmacophore guided the design of triazole substrates with increased cleavage efficiency and selectivity for cathepsin S over cathepsins B, L, and K. Conversion of select substrates to nitrile inhibitors yielded a low molecular weight (414 Da) and potent (15 nM) cathepsin S inhibitor that showed >1000-fold selectivity over cathepsins B, L, and K. PubMed: 17034136DOI: 10.1021/jm060701s PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.9 Å) |
Structure validation
Download full validation report